93699-37-7 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
1-(4-(4-Bromophenoxy)butyl)-4-Methylpiperazine is used as a ligand for various receptors in the central nervous system, aiding in the development of new drugs targeting these receptors. Its interaction with these receptors can provide insights into their structure and function, which is crucial for designing effective therapeutic agents.
Used in the Synthesis of Pharmacologically Active Compounds:
1-(4-(4-Bromophenoxy)butyl)-4-Methylpiperazine is used as a building block in the synthesis of other pharmacologically active compounds. Its unique structure and functional groups make it a valuable component in the development of novel drugs with potential applications in various therapeutic areas.
Used in the Study of Receptor Structure and Function:
1-(4-(4-Bromophenoxy)butyl)-4-Methylpiperazine is used as a tool compound for studying the structure and function of receptors in the central nervous system. Understanding the interactions between 1-(4-(4-broMophenoxy)butyl)-4-Methylpiperazine and its target receptors can contribute to the advancement of receptor-based drug discovery and the development of more targeted and effective treatments for various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 93699-37-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,6,9 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 93699-37:
(7*9)+(6*3)+(5*6)+(4*9)+(3*9)+(2*3)+(1*7)=187
187 % 10 = 7
So 93699-37-7 is a valid CAS Registry Number.
93699-37-7Relevant academic research and scientific papers
INDOLE AND INDAZOLE COMPOUNDS THAT ACTIVATE AMPK
-
Paragraph 0954; 0955, (2013/10/22)
The present invention relates to indole and indazole compounds of Formula (I) that activate 5′ adenosine monophosphate-activated protein kinase (AMPK). The invention also encompasses pharmaceutical compositions containing these compounds and methods for treating or preventing diseases, conditions, or disorders ameliorated by activation of AMPK.
Synthesis and preliminary evaluation of novel analogues of quindolines as potential stabilisers of telomeric G-quadruplex DNA
Le Sann, Christine,Huddleston, Jonathan,Mann, John
, p. 12903 - 12911 (2008/03/27)
Telomeric DNA is a potential selective target for cancer therapy since the tumour-associated enzyme telomerase regulates telomere maintenance in most cancer cells. The 3′ single-stranded ends of telomeric DNA can be folded into quadruplex structures by appropriate small molecules. We describe the preparation of a new class of 2,7-disubstituted 10H-indolo[3,2-b]quinolines with enhanced selectivity for the stabilisation of quadruplex DNA compared to duplex DNA, and also the preparation of a key intermediate for the synthesis of trisubstituted quindolines.
